Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

74,696 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Cryo-EM structure of the varicella-zoster virus A-capsid.
Sun J, Liu C, Peng R, Zhang FK, Tong Z, Liu S, Shi Y, Zhao Z, Zeng WB, Gao GF, Shen HJ, Yang X, Luo M, Qi J, Wang P. Sun J, et al. Among authors: yang x. Nat Commun. 2020 Sep 22;11(1):4795. doi: 10.1038/s41467-020-18537-y. Nat Commun. 2020. PMID: 32963252 Free PMC article.
Development of an Inactivated Vaccine Candidate, BBIBP-CorV, with Potent Protection against SARS-CoV-2.
Wang H, Zhang Y, Huang B, Deng W, Quan Y, Wang W, Xu W, Zhao Y, Li N, Zhang J, Liang H, Bao L, Xu Y, Ding L, Zhou W, Gao H, Liu J, Niu P, Zhao L, Zhen W, Fu H, Yu S, Zhang Z, Xu G, Li C, Lou Z, Xu M, Qin C, Wu G, Gao GF, Tan W, Yang X. Wang H, et al. Among authors: yang x. Cell. 2020 Aug 6;182(3):713-721.e9. doi: 10.1016/j.cell.2020.06.008. Epub 2020 Jun 6. Cell. 2020. PMID: 32778225 Free PMC article.
Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV: a randomised, double-blind, placebo-controlled, phase 1/2 trial.
Xia S, Zhang Y, Wang Y, Wang H, Yang Y, Gao GF, Tan W, Wu G, Xu M, Lou Z, Huang W, Xu W, Huang B, Wang H, Wang W, Zhang W, Li N, Xie Z, Ding L, You W, Zhao Y, Yang X, Liu Y, Wang Q, Huang L, Yang Y, Xu G, Luo B, Wang W, Liu P, Guo W, Yang X. Xia S, et al. Among authors: yang x, yang y. Lancet Infect Dis. 2021 Jan;21(1):39-51. doi: 10.1016/S1473-3099(20)30831-8. Epub 2020 Oct 15. Lancet Infect Dis. 2021. PMID: 33069281 Free PMC article. Clinical Trial.
Safety and immunogenicity of an inactivated COVID-19 vaccine, BBIBP-CorV, in people younger than 18 years: a randomised, double-blind, controlled, phase 1/2 trial.
Xia S, Zhang Y, Wang Y, Wang H, Yang Y, Gao GF, Tan W, Wu G, Xu M, Lou Z, Huang W, Xu W, Huang B, Wang W, Zhang W, Li N, Xie Z, Zhu X, Ding L, You W, Zhao Y, Zhao J, Huang L, Shi X, Yang Y, Xu G, Wang W, Liu P, Ma M, Qiao Y, Zhao S, Chai J, Li Q, Fu H, Xu Y, Zheng X, Guo W, Yang X. Xia S, et al. Among authors: yang x, yang y. Lancet Infect Dis. 2022 Feb;22(2):196-208. doi: 10.1016/S1473-3099(21)00462-X. Epub 2021 Sep 15. Lancet Infect Dis. 2022. PMID: 34536349 Free PMC article. Clinical Trial.
Twelve-month specific IgG response to SARS-CoV-2 receptor-binding domain among COVID-19 convalescent plasma donors in Wuhan.
Li C, Yu D, Wu X, Liang H, Zhou Z, Xie Y, Li T, Wu J, Lu F, Feng L, Mao M, Lin L, Guo H, Yue S, Wang F, Peng Y, Hu Y, Wang Z, Yu J, Zhang Y, Lu J, Ning H, Yang H, Fu D, He Y, Zhou D, Du T, Duan K, Dong D, Deng K, Zou X, Zhang Y, Zhou R, Gao Y, Zhang X, Yang X. Li C, et al. Among authors: yang h, yang x. Nat Commun. 2021 Jul 6;12(1):4144. doi: 10.1038/s41467-021-24230-5. Nat Commun. 2021. PMID: 34230476 Free PMC article.
Author Correction: Twelve-month specific IgG response to SARS-CoV-2 receptor-binding domain among COVID-19 convalescent plasma donors in Wuhan.
Li C, Yu D, Wu X, Liang H, Zhou Z, Xie Y, Li T, Wu J, Lu F, Feng L, Mao M, Lin L, Guo H, Yue S, Wang F, Peng Y, Hu Y, Wang Z, Yu J, Zhang Y, Lu J, Ning H, Yang H, Fu D, He Y, Zhou D, Du T, Duan K, Dong D, Deng K, Zou X, Zhang Y, Zhou R, Gao Y, Zhang X, Yang X. Li C, et al. Among authors: yang h, yang x. Nat Commun. 2021 Aug 5;12(1):4846. doi: 10.1038/s41467-021-25109-1. Nat Commun. 2021. PMID: 34354086 Free PMC article. No abstract available.
Safety and immunogenicity of a hybrid-type vaccine booster in BBIBP-CorV recipients in a randomized phase 2 trial.
Kaabi NA, Yang YK, Du LF, Xu K, Shao S, Liang Y, Kang Y, Su JG, Zhang J, Yang T, Hussein S, ElDein MS, Yang SS, Lei W, Gao XJ, Jiang Z, Cong X, Tan Y, Wang H, Li M, Mekki HM, Zaher W, Mahmoud S, Zhang X, Qu C, Liu DY, Zhang J, Yang M, Eltantawy I, Hou JW, Lei ZH, Xiao P, Wang ZN, Yin JL, Mao XY, Zhang J, Qu L, Zhang YT, Yang XM, Wu G, Li QM. Kaabi NA, et al. Among authors: yang t, yang xm, yang yk, yang ss, yang m. Nat Commun. 2022 Jun 27;13(1):3654. doi: 10.1038/s41467-022-31379-0. Nat Commun. 2022. PMID: 35760812 Free PMC article. Clinical Trial.
74,696 results
You have reached the last available page of results. Please see the User Guide for more information.